Australia’s notifiable disease status, 2015: Annual report of the National Notifiable Diseases Surveillance System
DOI:
https://doi.org/10.33321/cdi.2019.43.6Keywords:
notifiable diseases, surveillance, AustraliaAbstract
In 2015, 67 diseases and conditions were nationally notifiable in Australia. States and territories reported a total of 320,480 notifications of communicable diseases to the National Notifiable Diseases Surveillance System, an increase of 16% on the number of notifications in 2014. In 2015, the most frequently notified diseases were vaccine preventable diseases (147,569 notifications, 46% of total notifications), sexually transmissible infections (95,468 notifications, 30% of total notifications), and gastrointestinal diseases (45,326 notifications, 14% of total notifications). There were 17,337 notifications of bloodborne diseases; 12,253 notifications of vectorborne diseases; 1,815 notifications of other bacterial infections; 710 notifications of zoonoses and 2 notifications of quarantinable diseases.
Downloads
References
National Health Security Act, 2007. Accessed on March 2015. Available at: http://www.comlaw.gov.au/Details/C2007A00174
National Health Security (National Notifiable Disease List) Instrument 2008. Accessed on March 2015. Available at: http://www.comlaw.gov.au/ComLaw/legislation/LegislativeInstrument1.nsf/0/7162D634C6DD1BAACA25740B0079D6B8?OpenDocument
Commonwealth of Australia Department of Health. National Health Security Agreement. Accessed on March 2015. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/ohp-nhs-agreement.htm
The Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia. Annual Surveillance Report 2015. UNSW Australia, Sydney NSW: The Kirby Institute; 2015.
Klug GM, Boyd A, Sarros S, Stehmann C, Simpson M, McLean CA, et al. Creutzfeldt-Jakob disease surveillance in Australia, update to December 2013. Commun Dis Intell 2014;38(4):E348-E355. Available at http://www.ncbi.nlm.nih.gov/pubmed/25631598
Communicable Diseases Network Australia. National Notifiable Diseases Surveillance System. 2015. Accessed on March 2015. Available at: www.health.gov.au/nndssdata
Australian Bureau of Statistics. Australian Demographic Statistics, December 2014. Canberra: Australian Bureau of Statistics; 2015. ABS Cat.No.3101.0. Available at http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/3101.0Main+Features1Dec%202014?OpenDocument
Australian Institute of Health and Welfare. Age-standardised rate – Identifying and definitional attributes. 2005. Accessed on 17 March 2015. Available at: http://meteor.aihw.gov.au/content/index.phtml/itemId/327276
Graham S, Guy RJ, Donovan B, McManus H, El-Hayek C, Kwan K, et al. Epidemiology of chlamydia and gonorrhea among Indigenous and non-Indigenous Australians, 2000–2009. Med J Aust 2012;197(11):642–646.
Hammerschlag M. Sexually transmitted diseases in sexually abused children: medical and legal implications. Sex Transm Infect 1998;74(3):167–174. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1758110/pdf/v074p00167.pdf
Australian Institute of Health and Welfare. National Health Data Dictionary 13.3; 2008. Available at: http://meteor.aihw.gov.au/content/index.phtml/itemId/367274
Australian Bureau of Statistics. Standard Australian Classification of Countries (SACC). Canberra: Australian Bureau of Statistics; 2011. Report No. 1269.0. Available at http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/1269.02011?OpenDocument
Chen MY, Fairley CK, Donovan B. Nowhere near the point of diminishing returns: correlations between chlamydia testing and notification rates in New South Wales. Aust N Z J Public Health 2005;29(3):249–253. Available at: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15991773
Hocking J, Fairley C, Counahan M, Crofts N. The pattern of notification and testing for genital Chlamydia trachomatis infection in Victoria, 1998–2000: an ecological analysis. Aust N Z J Public Health 2003;27(4):405-408.
Burckhardt F, Warner P, Young H. What is the impact of change in diagnostic test method on surveillance data trends in Chlamydia trachomatis infection? Sex Transm Infect 2006;82(1):24–30. Available at http://www.ncbi.nlm.nih.gov/pubmed/16461597
Chen MY, Karvelas M, Sundararajan V, Hocking JS, Fairley CK. Evidence for the effectiveness of a chlamydia awareness campaign: increased population rates of chlamydia testing and detection. Int J STD AIDS 2007;18(4):239–243. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17509173
Hammad A, Guy RJ, Fairley C, Wand H, Chen MY, Dickson B, et al. Understanding trends in genital Chlamydia trachomatis can benefit from enhanced surveillance: findings from Australia. Sex Transm Infect 2012;88(7):552–557.
Stephens N, O’Sullivan M, Coleman D, Shaw K. Chlamydia trachomatis in Tasmania 2001–2007: rising notification trends. Aust N Z J Public Health 2010;34(2):120-125.
National HBV Testing Policy Expert Reference Committee. National hepatitis B testing policy 2015 v1.2. ASHM, Darlinghurst, NSW: Commonwealth of Australia; 2015.
National HCV Testing Policy Expert Reference Committee. National hepatitis C testing policy 2012 v1.1. ASHM, Darlinghurst, NSW: Commonwealth of Australia; 2012.
Heyman D. Control of Communicable Diseases Manual. 20th edn. American Public Health Association; 2015.
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases. Hepatitis B Vaccines for Australians: Information for Immunisation Providers.
Australian Childhood Immunisation Register – annualised quarterly reports (December 2015, March 2016, June 2016 and September 2016). 2016. Accessed on 21 November.
Gidding HF, Warlow M, MacIntyre CR, Backhouse J, Gilbert GL, Quinn HE, et al. The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia. Vaccine 2007;25(51):8637–8641. Available at: http://www.sciencedirect.com/science/article/B6TD4-4PDK2FM-2/2/43b6862bf5e37521a11f7a11f280c7e7
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases. Significant events in hepatitis B vaccination practice in Australia. 2014. Accessed on July 2014. Available at: http://ncirs.edu.au/immunisation/history/Hepatitis-B-history-July-2014.pdf
Maclachlan JH, Towell T, Cowie BC. The burden of chronic hepatitis B virus infection in Australia, 2011. Aust N Z J Public Health 2013;37(5):416-422. Available at: http://onlinelibrary.wiley.com/doi/10.1111/1753-6405.12049/pdf
Naidu L, Chiu C, Habig A, Lowbridge C, Jayasinghe S, Wang H, et al. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006–2010. Commun Dis Intell 2013;37(Suppl):S1–S95. Available at: http://www.ncbi.nlm.nih.gov/pubmed/24410428
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases. Hepatitis B vaccines for Australians, NCIRS fact sheet: June 2012. 2012. Accessed on March 2015. Available at: http://www.ncirs.edu.au/immunisation/fact-sheets/hepatitis-B-fact-sheet.pdf
Australian Technical Advisory Group on Immunisation. The Australian Immunisation Handbook. 10th edn. Canberra, Australia: National Health and Medical Research Council and the Department of Health; 2013.
Australian insititute of Health and Welfare. National Drug Strategy Household Survey detailed report 2013. Canberra: AIHW; 2014.
Australian insititute of Health and Welfare. The health of Australia’s prisoners 2015. Canberra: AIHW; 2015.
Butler TG, Callander D, Simpson M. National Prison Entrants’ Bloodborne Virus Survey Report 2004, 2007, 2010 and 2013. Kirby Institute (UNSW Australia); 2015.
Razali K, Thein HH, Bell J, Cooper-Stanbury M, Dolan K, Dore G, et al. Modelling the hepatitis C virus epidemic in Australia. Drug Alcohol Depend 2007;91(2–3):228–235. Available at: http://www.sciencedirect.com/science/article/B6T63-4P9T9DN-1/2/c47a08209436db04e11be1d03794a93f
OzFoodNet Working Group. Monitoring the incidence and causes of diseases potentially transmitted by food in Australia: Annual report of the OzFoodNet Network, 2010. Commun Dis Intell 2012;36(3):E213–E241.
Donnan EJ, Fielding JE, Gregory JE, Lalor K, Rowe S, Goldsmith P, et al. A multistate outbreak of hepatitis A associated with semidried tomatoes in Australia, 2009. Clin Infect Dis 2012;54(6):775–781. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22238166
ATAGI. The Australian Immunisation Handbook. 10th edn. Canberra: Commonwealth of Australia; 2013.
Monitoring the incidence and causes of diseases potentially transmitted by food in Australia: annual report of the OzFoodNet Network, 2009. Commun Dis Intell Q Rep 2010;34(4):396–426.
Lamont RF, Sobel J, Mazaki-Tovi S, Kusanovic JP, Vaisbuch E, Kim SK, et al. Listeriosis in human pregnancy: a systematic review. J Perinat Med 2011;39(3):227-236. http://www.ncbi.nlm.nih.gov/pubmed/21517700
van den Beld MJ, Reubsaet FA. Differentiation between Shigella, enteroinvasive Escherichia coli (EIEC) and noninvasive Escherichia coli. (1435–4373).
Cumpston JHL. Health and disease in Australia. Canberra: Australian Government Publishing Service; 1989.
Grattan-Smith PJ ORW, Ellis PS, O’Flaherty SJ, McIntyre PB, Barnes CJ. Rabies. A second Australian case with a long incubation period. Med J Aust 1992;156(9):651–654.
Fenner F, Henderson D, Arita I, Jezek Z, Ladnyi I. Smallpox and its eradication. Geneva, Switzerland; 1988.
Australian Government Department of Health and Ageing. Guidelines for smallpox outbreak, preparedness, response and management. 2004. Accessed on 12/02/2019. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/health-pubhlth-publicat-document-metadata-smallpox.htm
NNDSS Annual Report Writing Group. Australia’s notifiable disease status, 2013: Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2015;39(3):E387–E477. Available at: http://www.ncbi.nlm.nih.gov/pubmed/26620352
Miller M, Roche P, Yohannes K, Spencer J, Bartlett M, Brotherton J, et al. Australia’s notifiable diseases status, 2003: Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2005;29(1):1–61.
World Health Organization. Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO. 2013. Accessed on 11/02/2019. Available at: http://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table_archives/en/index.html
Curran M, Harvey B, Crerar S. Annual report of the National Notifiable Diseases Surveillance System, 1996. Commun Dis Intell 1997;21:281–307.
Forssman B, Mannes T, Musto J, Gottlieb T, Robertson G, Natoli JD, et al. Vibrio cholerae O1 El Tor cluster in Sydney linked to imported whitebait. Med J Aust 2007;187(6):345–347. Available at: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17874982
Geisler W, Lensing S, Press C, Hook EW, 3rd edn. Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection. J Infect Dis 2013;207(12):1850–1856. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654745/
The Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2014; 2014.
Victoria Department of Health. Blue book: Guidelines for the control of infectious diseases. 2009. Accessed on 3 April 2014. Available at: http://ideas.health.vic.gov.au/bluebook/
Australasian Society for HIV Medicine. HIV, viral hepatitis and STIs: a guide for primary care providers. Darlinghurst: Australasian Society for HIV Medicine; 2014.
Bowden FJ, on behalf of the National Donovanosis Eradication Advisory Committee. Donovanosis in Australia: going, going ... Sex Transm Infect 2005;81(5):365–366. Available at: http://sti.bmj.com/cgi/content/abstract/81/5/365
Donovan B, Dimech W, Ali H, Guy R, Hellard M. Increased testing for Neisseria gonorrhoeae with duplex nucleic acid amplification tests in Australia: implications for surveillance. Sexual Health 2015;12(1):48–50.
Roberts-Witteveen A, Pennington K, Higgins N, Lang C, Lahra M, Waddell R, et al. Epidemiology of gonorrhoea notifications in Australia, 2007–12. Sex Health 2014;11(4):324–331. Available at: http://www.publish.csiro.au/paper/SH13205
Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine. Australian STI management guidelines for use in primary care. 2016. Accessed on 27 January. Available at: http://sti.guidelines.org.au/
Communicable Diseases Network Australia. Syphilis – infectious (primary, secondary and early latent), less than 2 years duration case definition. 2015. Accessed on 27 January. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-cd_syphl2.htm
Australian Bureau of Statistics. Census of Population and Housing: Characteristics of Aboriginal and Torres Strait Islander Australians, 2011, ABS. cat. no. 2076.0. Canberra: ABS; 2011.
Prestage G, Ferris J, Grierson J, Thorpe R, Zablotska I, Imrie J, et al. Homosexual men in Australia: population, distribution and HIV prevalence. Sex Health 2008;5(2):97–102. Available at http://www.ncbi.nlm.nih.gov/pubmed/18588772
Centre for Disease Control Northern Territory. Syphilis outbreak in the NT: 2015 update. The Northern Territory Disease Control Bulletin 2015;22(1):1–30. Available at: http://www.health.nt.gov.au/library/scripts/objectifyMedia.aspx?file=pdf/98/71.pdf&siteID=1&str_title=Bulletin%20March%202015.pdf
Ward J, Guy RJ, Akre S, Middleton M, Giele C, Su J, et al. Epidemiology of syphilis in Australia: moving toward elimination of infectious syphilis from Aboriginal and Torres Strait Islander communities? Med J Aust 2011;194(10):525–529.
Australian Government Department of Health. Fourth National Aboriginal and Torres Strait Islander Blood-borne Viruses and Sexually Transmissible Infections Strategy, 2014–2014. Canberra: Australian Government Department of Health; 2014.
Australian Government Department of Health. Third National Sexually Transmissible Infections Strategy 2014–2017. Canberra: Australian Government Department of Health; 2014.
Impact of vaccines universally recommended for children. 1900–1998. MMWR Morb Mortal Wkly Rep 1999;48(12):243–248.
Andre FE, Booy R, Bock HL, Clemens J, Datta SK, John TJ, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ 2008;86(2):81–60.
Ehreth J. The global value of vaccination. Vaccine 2003;21(7–8):596–600.
Préziosi M, Halloran ME. Effects of pertussis vaccination on disease: Vaccine efficacy in reducing clinical severity. Clin Infect Dis 2003;37(6):772–779.
Schlenker TL, Bain C, Baughman AL, Hadler SC. Measles herd immunity: the association of attack rates with immunization rates in preschool children. JAMA 1992;267(6):823–826.
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases. Haemophilus influenzae type b (Hib) vaccines for Australian children, NCIRS Fact sheet: October 2009. Sydney: National Centre for Immunisation Research and Surveillance for Vaccine Preventable Diseases; 2009.
Chandran A, Watt J, Santosham M. Haemophilus influenzae. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. Philadelphia, PA, USA: Saunders Elsevier; 2008.
Punpanich W, Chotpitayasunondh T. A review on the clinical spectrum and natural history of human influenza. Int J Infect Dis 2012;16(10):E714-E723. Available at: http://www.sciencedirect.com/science/article/pii/S1201971212011770
Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008;167:775–785.
Mauskopf J, Klesse M, Lee S, Herrera-Taracena G. The burden of influenza complications in different high-risk groups: a targeted literature review. J Med Econ 2013;16(2):264–277. Available at http://informahealthcare.com/doi/abs/10.3111/13696998.2012.752376
Bennett JE, Dolin R, Blaser MJ. Principles and Practice of Infectious Diseases. 8th edn. Elsevier Health Sciences; 2014.
Barr I, Vijaykrishna D, Sulliva S. Differential age susceptibility to influenza B/Victoria lineage viruses in the 2015 Australian influenza season. Eurosurveillance 2016;21(4).
University of Adelaide. National GP Sentinel Surveillance Fortnightly Report No. 26, 2015. 2015. Accessed on 13 February 2017. Available at: https://aspren.dmac.adelaide.edu.au/documents/20714/23808/ASPREN+Report+No+26+2015/0b8511e8-0193-42c9-b4ef-a0bbc9b2f6e0?version=1.1
Centers for Disease Control and Prevention. Measles. In: Atkinson W, Wolfe C, Hamborsky J, editors. Epidemiology and prevention of vaccine preventable diseases. 12th edn. Washington, D.C.: Public Health Foundation; 2011.
World Health Organization. Measles. In: Disease Fact Sheets. Geneva; 2014.
Strebel P, Papania M, Dayan G, Halsey N. Vaccines. In: Plotkin SA, Orenstein WA, Offit PA, editors. Philadelphia: Saunders Elsevier; 2008.
Heywood AE, Gidding HF, Riddell MA, McIntyre PB, MacIntyre CR, Kelly HA. Elimination of endemic measles transmission in Australia. Bull World Health Organ 2009;87(1):64–71.
Gidding H, Wood J, MacIntyre CR, Kelly H, Lambert SB, Gilbert GL, et al. Sustained measles elimination in Australia and priorities for long-term maintenance. Vaccine 2007;25(18):3574–3580.
Gidding HF, Gilbert GL. Measles immunity in young Australian adults. Commun Dis Intell 2001;25(3):133–136.
Australian Government Department of Health. The Australian Immunisation Handbook. 10th edn. 2016.
de Serres G, Gay NJ, Farrington CP. Epidemiology of transmissible diseases after elimination. Am J Epidemiol 2000;151(11):1039-1048.
World Health Organization. Four Western Pacific countries and areas are the first in their Region to be measles-free. 2014. Accessed on 12/02/2019. https://www.who.int/westernpacific/news/detail/20-03-2014-four-western-pacific-countries-and-areas-are-the-first-in-their-region-to-be-measles-free
Gidding HF, Martin NV, Stambos V, Tran T, Dey A, Dowse GK, et al. Verification of measles elimination in Australia: Application of World Health Organization regional guidelines. Journal of Epidemiology and Global Health 2016;6(3):197–209. Available at: http://www.sciencedirect.com/science/article/pii/S2210600615300903
Plotkin SA, Rubin S. Mumps vaccine. 5th edn. Philadelphia, PA: Saunders Elsevier; 2008.
Westphal D, Huppatz C, Eastwood A, Davies J, Lyttle H, Gilles M, et al. The epidemiology of a large mumps outbreak in Western Australia 2015–2016. In: Government of Western Australia Department of Health, PathWest, Australian National University, Telethon Kids Institute, editors. Communicable Diseases Control Conference, Infectious Diseases: a global challenge. Melbourne, Australia: Public Health Association of Australia; 2017. p. 7.
Bangor-Jones RD, Dowse GK, Giele CM, van Buynder PG, Hodge MM, Whitty MM. A prolonged mumps outbreak among highly vaccinated Aboriginal people in the Kimberley region of Western Australia. Med J Aust 2009;191(7):4.
Westphal D, Giele C, Levy A, Chuad J, Williams S, Effler P, et al. A second prolonged mumps outbreak in highly vaccinated Aboriginal Western Australians. In: Government of Western Australia Department of Health, PathWest, Australian National University, Telethon Kids Institute, editors. Public Health Association of Australia 15th National Immunisation Conference. Brisbane, Australia; 2016.
Deeks S, Lim G, Simpson M, Gagné L, Kristjanson E, Fung C, et al. An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada. Can Med Assoc J 2011;183(9):1014–1020.
Demicheli V, Rivetti A, Debalini M, Di Pietrantonj C. Vaccines for measles, mumps and rubella in children. Cochrane Database Sys Rev 2012;2:CD004407.
Gupta R, Best J, MacMahon E. Mumps and the UK epidemic 2005. BMJ 2005;330:1132–1135.
Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, et al. Recent resurgence of mumps in the United States. N Engl J Med 2008;358(15):1580–1589.
Whelan J, Van Binnendijk R, Greenland K, Fanoy E, Kharqi M, Yap K, et al. Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands. Euro Surveill 2010;15(17):pii:19554.
Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, et al. Vaccine effectiveness estimates, 2004–2005 mumps outbreak, England. Emerg Infect Dis 2007;13(1):12–17.
Pertussis. In: Atkinson W, Wolfe C, Hamborsky J, editors. Epidemiology and prevention of vaccine preventable diseases. 12th edn. Washington, DC: Public Health Foundation, Centers for Disease Control and Prevention; 2011.
Communicable Diseases Network Australia. Series of National Guidelines: Pertussis. 2013. Accessed on March 2015. Available at: https://www.health.gov.au/internet/main/publishing.nsf/Content/cdna-song-pertussis.htm
Quinn H, McIntyre PB. Impact of removal of the 18 month DTPa dose on pertussis vaccine effectiveness. In: 12th National Immunisation Conference. Adelaide, South Australia; 2010.
Quinn HE, Snelling TL, Macartney KK, McIntyre PB. Duration of protection after first dose of acellular pertussis vaccine in infants. Pediatrics 2014;133(3):E513-E519. Available at http://pediatrics.aappublications.org/content/early/2014/02/04/peds.2013-3181.abstract
Sheridan SL, McCall BJ, Davis CA, Robson JM, Hull BP, Selvey CE, et al. Acellular pertussis vaccine effectiveness for children during the 2009–2010 pertussis epidemic in Queensland. Med J Aust 2014;200(6):334–338.
Wendelboe AM, van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005;24(5 Suppl):S58-S61.
Munoz FM. Pertussis in infants, children, and adolescents: diagnosis, treatment, and prevention. Semin Pediatr Infect Dis 2006;17(1):14–19.
Beard F. Pertussis immunisation in pregnancy: a summary of funded Australian state and territory programs. Communicable Disease Intelligence 2015;39(3):E329–E336. Available at: http://www.health.gov.au/internet/main/publishing.nsf/content/cda-cdi3903c.htm
National Health and Medical Research Council (NHMRC). The Australian Immunisation Handbook. 10th edn. Canberra: Australian Government; 2013.
World Health Organization. WHO-recommended surveillance standard of poliomyelitis. 2017. Accessed on 27 November. Available at: http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/active/poliomyelitis_standards/en/
The Australian Department of Health. Polio – Australian National Enterovirus Reference Laboratory annual reports. 2015. Accessed on 27 November. Available at: http://www.health.gov.au/internet/main/publishing.nsf/content/cda-pubs-annlrpt-polioanrep.htm
Global Polio Eradication Initiative. Wild Polio Virus List 2017. Accessed on 22 November 2017. Available at: http://polioeradication.org/polio-today/polio-now/wild-poliovirus-list/
World Health Organization Western Pacific Regional Office. Polio Bulletin – Week 1 as of 5 January 2016: World Health Organization; 2016.
McLean H, Redd S, Abernathy E, Icenogle J, Wallace G. Chapter 15: Congenital rubella syndrome. In: Manual for the Surveillance of Vaccine-Preventable Diseases. Atlanta: Centers for Disease Control and Prevention; 2012.
Song N, Gao Z, Wood J, Hueston L, Gilbert C, MacIntyre R, et al. Current epidemiology of rubella and congenital rubella syndrome in Australia: Progress towards elimination. Vaccine 2012;30(27):4073–4078.
Western Pacific Regional Office. Rubella and congenital rubella syndrome Geneva: World Health Organization; 2012.
Khandaker G, Zyrynski Y, Jones C. Surveillance for congenital rubella syndrome in Australia since 1993: cases reported between 2004 and 2013. Vaccine 2014;32(50):6746–6751.
Quinn H, McIntyre P. Tetanus in the elderly – An important preventable disease in Australia. Vaccine 2007;25(7):1304–1309.
Mackenzie JS, Lindsay MD, Coelen RJ, Broom AK, Hall RA, Smith DW. Arboviruses causing human disease in the Australasian zoogeographic region. Arch Virol 1994;136(3–4):447-467. Available at: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8031248
Russell RC, Dwyer DE. Arboviruses associated with human disease in Australia. Microbes Infect 2000;2(14):1693–1704.
Communicable Diseases Network Australia. Australian National Notifiable Diseases Case Definitions. 2016. Accessed on 18 October 2016. Available at: http://www.health.gov.au/casedefinitions
Parida MM, Santhosh SR, Dash PK, Lakshmana Rao PV. Rapid and real-time assays for detection and quantification of chikungunya virus. Future Virol 2008;3(2):179–192.
Harrington S, Lindsay M, Douglas A. Christmas Island and Cocos (Keeling) Islands, Indian Ocean: Mosquito fauna and mosquito-borne disease risk assessment and management recommendations. Final report of investigations undertaken in 2007–08: Public Health Division, Western Australian Department of Health; 2009.
Pacific Public Health Surveillance Network. Chikungunya in the Pacific region. In: Email to members of PacNet; 2015.
World Health Organization. Dengue and severe dengue. 2016. Available at: http://www.who.int/mediacentre/factsheets/fs117/en/
Guzman MG, Kouri G, Martinez E, Bravo J, Riveron R, Soler M, et al. Clinical and serologic study of Cuban children with dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). Bull Pan Am Health Organ 1987;21(3):270–279.
Mackenzie JS, Gubler DJ, Petersen LR. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 2004;10(12 Suppl):S98–S109. Available at: http://search.ebscohost.com/login.aspx?direct=true&db=mnh&AN=15577938&site=ehost-live
Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000;181(1):2–9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/10608744
Queensland Health. Queensland Dengue Management Plan 2015–2020.
Knope K, Muller M, Kurucz N, Doggett S, Feldman R, Johansen C, et al. Arboviral diseases and malaria in Australia, 2013–14: annual report of the National Arbovirus and Malaria Advisory Committee. Commun Dis Intell 2016;40(3).
Whelan P, Nguyen H, Hajkowicz K, Davis J, Smith D, Pyke A, et al. Evidence in Australia for a Case of Airport Dengue. PLoS Negl Trop Dis 2012;6(9):e1619. Available at http://dx.doi.org/10.1371%2Fjournal.pntd.0001619
Lindsay MD, Jardine A, Giele C, Armstrong P, McCarthy S, Whittle A, et al. Investigation of the first case of dengue virus infection acquired in Western Australia in seven decades: Evidence of importation of infected mosquitoes? PLoS Negl Trop Dis 2015;9(9):E0004114. Available at: http://www.ncbi.nlm.nih.gov/pubmed/26406471
Knope K, National Arbovirus and Malaria Advisory Committee, Giele, C. Increasing notifications of dengue related to overseas travel, 1991 to 2012. Commun Dis Intell 2013;37(1):E55–E59.
Tonga Ministry of Health. Situation report and update on the dengue fever outbreak in Tonga. In: Email to PacNet members; 2015.
Musso D, Roche C, Robin E, Nhan T, Teissier A, Cao-Lormeau VM. Potential sexual transmission of Zika virus. Emerg Infect Dis 2015;21(2):359–361. Available at: http://www.ncbi.nlm.nih.gov/pubmed/25625872
Ministério da Saúde (Brazil). Confirmação do Zika Vírus no Brasil, [Internet]. Brasília: Ministério da Saúde (Brazil); 2015 [updated 14 May 2015; cited 14 May 2015]. Available at: http://portalsaude.saude.gov.br/index.php/cidadao/principal/agencia-saude/17701-confirmacao-do-zika-virus-no-brasil.
Cardoso CW, Paploski IA, Kikuti M, Rodrigues MS, Silva MM, Campos GS, et al. Outbreak of exanthematous illness associated with Zika, chikungunya, and dengue viruses, Salvador, Brazil. Emerg Infect Dis 2015;21(12):2274–2276. Available at:http://www.ncbi.nlm.nih.gov/pubmed/26584464
World Health Organization. WHO statement on the first meeting of the International Health Regulations (2005) (IHR 2005) Emergency Committee on Zika virus and observed increase in neurological disorders and neonatal malformations. 2016. Accessed on 17 February 2016. Available at: http://www.who.int/mediacentre/news/statements/2016/1st-emergency-committee-zika/en/
Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. Zika virus and birth defects – reviewing the evidence for causality. N Engl J Med 2016;374(20):1981–1987. Available at http://www.ncbi.nlm.nih.gov/pubmed/27074377
Cao-Lormeau VM, Blake A, Mons S, Lastere S, Roche C, Vanhomwegen J, et al. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 2016;387(10027):1531–1539. Available at http://www.ncbi.nlm.nih.gov/pubmed/26948433
Paploski IA, Prates AP, Cardoso CW, Kikuti M, Silva MM, Waller LA, et al. Time lags between exanthematous illness attributed to Zika virus, Guillain-Barré syndrome, and microcephaly, Salvador, Brazil. Emerg Infect Dis 2016;22(8):1438–1444.
McCarthy M. Zika virus was transmitted by sexual contact in Texas, health officials report. BMJ 2016;352. Available at: http://www.bmj.com/bmj/352/bmj.i720.full.pdf
Foy BD, Kobylinski KC, Chilson Foy JL, Blitvich BJ, Travassos da Rosa A, Haddow AD, et al. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis 2011;17(5):880–882. Available at http://www.ncbi.nlm.nih.gov/pubmed/21529401
Atkinson B, Hearn P, Afrough B, Lumley S, Carter D, Aarons E, J., et al. Detection of Zika Virus in semen. Emerg Infect Dis 2016;22(5). Available at: http://wwwnc.cdc.gov/eid/article/22/5/16-0107
Deckard DT, Chung WM, Brooks JT, Smith JC, Woldai S, Hennessey M, et al. Male-to-Male Sexual Transmission of Zika Virus – Texas, January 2016. MMWR Morb Mortal Wkly Rep 2016;65(14):372–374. Available at: http://www.ncbi.nlm.nih.gov/pubmed/27078057
Davidson A, Slavinski S, Komoto K, Rakeman J, Weiss D. Suspected Female-to-Male Sexual Transmission of Zika Virus – New York City, 2016. MMWR Morb Mortal Wkly Rep 2016;65(28):716–717. Available at: http://www.ncbi.nlm.nih.gov/pubmed/27442327
Pacific Public Health Surveillance Network. Pacific Syndromic Surveillance Reports 16 March to 21 May 2015. 2015. Accessed on 12 October 2016. Available at: http://www.wpro.who.int/southpacific/programmes/communicable_diseases/disease_surveillance_response/page/en/index2.html
Hanna JN, Ritchie SA, Phillips DA, Lee JM, Hills SL, van den Hurk AF, et al. Japanese encephalitis in north Queensland, Australia, 1998. Med J Aust 1999;170(11):533–536. Available at: http://search.ebscohost.com/login.aspx?direct=true&db=mnh&AN=10397044&site=ehost-live
Cox-Singh J, Davis TM, Lee KS, Shamsul SS, Matusop A, Ratnam S, et al. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clin Infect Dis 2008;46(2):165–171. Available at: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18171245
Gray TJ, Trauer JM, Fairley M, Krause VL, Markey PG. Imported malaria in the Northern Territory, Australia – 428 consecutive cases. Commun Dis Intell 2012;36(1):107-113. Available at http://www.ncbi.nlm.nih.gov/pubmed/23153087
Hanna JN, Ritchie SA, Eisen DP, Cooper RD, Brookes DL, Montgomery BL. An outbreak of Plasmodium vivax malaria in Far North Queensland, 2002. Med J Aust 2004;180(1):24–28. Available at: http://www.ncbi.nlm.nih.gov/pubmed/14709124
World Health Organization. World Malaria Report 2015. Accessed on 8 July 2016. Available at: http://apps.who.int/iris/bitstream/10665/200018/1/9789241565158_eng.pdf?ua=1
Knope K, Whelan P, Smith D, Johansen C, Moran R, Doggett S, et al. Arboviral diseases and malaria in Australia, 2010–11: annual report of the National Arbovirus and Malaria Advisory Committee. Commun Dis Intell 2013;37(1):E1–E20.
World Health Organization. Zoonoses. Technical report series no. 169. Geneva, Switzerland: World Health Organization; 1959.
Taylor LH, Latham SM, Woolhouse ME. Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci 2001;356(1411):983–989.
Jones KE, Patel NG, Levy MA. Global trends in emerging infectious diseases. Nature 2008(451):990–994.
Woolhouse MEJ, Gowtage-Sequeria S. Host range and emerging and re-emerging pathogens. Emerg Infect Dis 2005;11(12):1842–1847.
World Health Organization. Report of the WHO/FAO/OIE joint consultation on emerging zoonotic diseases. Geneva, Switzerland: World Health Organization; 2004.
Animal Health Australia. Animal Health in Australia, 2015. In: Animal Health Australia, Canberra; 2015.
Kolbe A, Yuen M, Doyle B. A case of human cutaneous anthrax. Med J Aust 2006;185(5):281–282.
Fielding J. Zoonoses: Anthrax. Victorian Infectious Diseases Bulletin 2007;10(2):47.
NSW Department of Health. Communicable Diseases Report, NSW, January and February 2010. N S W Public Health Bull 2010;21(3–4):103-107. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20513312
Calisher CH, Ellison JA. The other rabies viruses: The emergence and importance of lyssaviruses from bats and other vertebrates. Travel Med Infect Dis 2012;10(2):69–79. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22386761
Fraser GC, Hooper PT, Lunt RA, Gould AR, Gleeson LJ, Hyatt AD, et al. Encephalitis caused by a lyssavirus in fruit bats in Australia. Emerg Infect Dis 1996;2(4):327–331. Available at: http://www.ncbi.nlm.nih.gov/pubmed/8969249
Hooper PT, Lunt RA, Gould AR, Samaratunga H, Hyatt AD, Gleeson LJ, et al. A new lyssavirus – the first endemic rabies-related virus recognized in Australia. Bulletin de l’Institut Pasteur 1997;95(4):209–218. Available at: http://www.sciencedirect.com/science/article/pii/S0020245297835295
Communicable Diseases Network Australia. Series of National Guidelines: Rabies virus and other lyssavirus including Australian bat lyssavirus) exposures and infections. 2013. Accessed on 7 June 2015. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/cdna-song-abvl-rabies.htm
Allworth A, Murray K, Morgan J. A human case of encephalitis due to a lyssavirus recently identified in fruit bats. Commun Dis Intell 1996;20(24):504.
Hanna JN, Carney IK, Smith GA, Tannenberg AEG, Deverill JE, Botha JA, et al. Australian bat lyssavirus infection: a second human case, with long incubation period. Med J Aust 2000;172(12):597–599.
Francis JR, Nourse C, Vaska VL, Calvert S, Northill JA, McCall B, et al. Australian bat lyssavirus in a child: The first reported case. Pediatrics 2014;133(4):E1063–E1067. Available at: http://www.ncbi.nlm.nih.gov/pubmed/24590754
Queensland Department of Agriculture. Australian bat lyssavirus overview. In: Animal Health and Diseases: Queensland Government; 2013.
Crook A. Australian bat lyssavirus communiqué. In: Department of Agriculture, Fisheries and Forestry; 2013.
Bat Health Focus Group. ABLV Bat Stats, Australian Bat Lyssavirus report – December 2015. Wildlife Health Australia 2016. Available at: https://wildlifehealthaustralia.com.au/Portals/0/Documents/ProgramProjects/ABLV%20BAT%20STATS%20Dec%202015.pdf
Animal Health Australia. Animal Health in Australia 2012. Canberra; 2013. Available at: http://www.animalhealthaustralia.com.au/wp-content/uploads/2011/01/AHIA-2012-full-report.pdf
Eales KM, Norton RE, Ketheesan N. Brucellosis in northern Australia. Am J Trop Med Hyg 2010;83(4):876–878. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20889883
Communicable Diseases Branch. NSW Zoonoses Annual Surveillance Report: 2015. Sydney; 2016. Available at: http://www.health.nsw.gov.au/Infectious/reports/Documents/nsw-zoonoses-annual-report-2015.pdf
Levett PN. Leptospirosis. Clin Microbiol Rev 2001;14(2):296-326.
World Health Organization, Society IL. Human Leptospirosis: Guidance for Diagnosis, Surveillance and Control; 2003. Available at: http://whqlibdoc.who.int/hq/2003/WHO_CDS_CSR_EPH_2002.23.pdf?ua=1
O’Leary FM, Hunjan JS, Bradbury R, Thanakrishnan G. Fatal leptospirosis presenting as musculoskeletal chest pain. Med J Aust 2004;180(1):29-31. Available at http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14709125
Beeckman DS, Vanrompay DC. Zoonotic Chlamydophila psittaci infections from a clinical perspective. Clin Microbiol Infect 2009;15(1):11–17. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19220335
Deschuyffeleer TP, Tyberghien LF, Dickx VL, Geens T, Saelen JM, Vanrompay DC, et al. Risk assessment and management of Chlamydia psittaci in poultry processing plants. Ann Occup Hyg 2012;56(3):340–349. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22302240
McCaul TF, Williams JC. Developmental cycle of Coxiella burnetii: structure and morphogenesis of vegetative and sporogenic differentiations. J Bacteriol 1981;147(3):1063-1076. Available at: http://www.ncbi.nlm.nih.gov/pubmed/7275931
Lowbridge CP, Tobin S, Seale H, Ferson MJ. Notifications of Q fever in NSW, 2001–2010. N S W Public Health Bull 2012;23(1-2):31–35.
Bell M, Patel M, Sheridan J. Q fever vaccination in Queensland abattoirs. Commun Dis Intell 1997;21(3):29–31. Available at: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9079588
Lin M, Delpech V, McAnulty J, Campbell-Lloyd S. Notifications of Q fever in New South Wales, 1991–2000: EpiReview. N S W Public Health Bull 2001;12(6):172–175.
Gidding HF, Wallace C, Lawrence GL, McIntyre PB. Australia’s National Q Fever Vaccination Program. Vaccine 2009;27(14):2037–2041. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19428827
Ellis J, Oyston PC, Green M, Titball RW. Tularemia. Clin Microbiol Rev 2002;15(4):631–646. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12364373
Jackson J, McGregor A, Cooley L, Ng J, Brown M, Ong CW, et al. Francisella tularensis subspecies holarctica, Tasmania, Australia, 2011. Emerg Infect Dis 2012;18(9):1484–1486. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22931809
Veitch M. The public health response to tularemia in Tasmania. In: Communicable Disease Control Conference 2013. Canberra, Australia; 2013.
NNDSS Annual Report Writing Group. Australia’s notifiable disease status, 2011: Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2013;37(4):E313–393. Available at http://www.ncbi.nlm.nih.gov/pubmed/24882235
de Jong B. Legionella, springtime and potting soils. Euro Surveill 2010;15(8):19497.
O’Connor B, Carman J, Eckert K, Tucker G, Givney R, Cameron S. Does potting mix make you sick? Results for a Legionella longbeachae case-control study in South Australia. Epidemiol Infect 2007;135(1):34–39.
Pravinkumar SJ, Edwards G, Lindsay D, Redmond S, Stirling J, House R, et al. A cluster of legionnaire’s disease caused by Legionella longbeachae linked to potting compost in Scotland, 2008–2009. Euro Surveill 2010;15(8):19496.
Whiley H, Bentham R. Legionella longbeachae and legionellosis. Emerg Infect Dis 2011;17(4):579–583.
Li J, O’Brien ED, Guest C. A review of national legionellosis surveillance in Australia, 1991 to 2000. Commun Dis Intell 2002;26:462–470.
Rota MC, Caporal MG, Bella A, Ricci ML, Napoli C. Legionnaires disease in Italy: results of the epidemiological surveillance from 2000 to 2011. Euro Surveill 2013;18(23).
World Health Organization. Leprosy – Fact Sheet No. 101. 2015. Accessed on 19 June 2015. Available at: http://www.who.int/mediacentre/factsheets/fs101/en/
Communicable Diseases Network Australia. Meningococcal disease (invasive) surveillance case definition – V1.4. 2009. Accessed on 6 July 2015. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-cd_mening.htm
Jafri RZ, Ali A, Messonnier NE, Tevi-Benissan C, Durrheim D, Eskola J, et al. Global Epidemiology of invasive meningococcal disease. Population Health Metrics 2013;11(17).
Lahra M, Enriquez R, National Neisseria Network. Australian Meningococcal Surveillance Programme annual report, 2015 Comm Dis Intell 2016;40(4).
Martin N, Ong K, Howden B, Lahra M, Lambert S, Beard F, et al. Rise in invasive serogroup W meningococcal disease in Australia, 2013–2015. Comm Dis Intell 2016;40(4).
Bareja C, Waring J, Stapledon R, National Tuberculosis Advisory Committee for the Communicable Diseases Network Australia. Tuberculosis notifications in Australia, 2010. Commun Dis Intell 2014;38(1):E36–E48.
Luca S, Mihaescu T. History of BCG Vaccine. Maedica (Burchar) 2013;8(1):53–58. Available at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749764/pdf/maed-08-53.pdf
Public Health England. Tuberculosis: the green book, chapter 32. In: Immunisation against infectious disease. London: Department of Health; 2013. p. 394.
National Tuberculosis Advisory Committee. The BCG vaccine: Information and recommendations for use in Australia. Commun Dis Intell 2013;37(1):E65–E72.
Australian Government Department of Health. Tuberculosis notifications in Australia annual reports. 2014. Accessed on 2 November 2016. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-pubs-annlrpt-tbannrep.htm
Zika virus outbreak on Yap Island, Federated States of Micronesia.Duffy MR1, Chen TH, Hancock WT, Powers AM, Kool JL, Lanciotti RS, Pretrick M, Marfel M, Holzbauer S, Dubray C, Guillaumot L, Griggs A, Bel M, Lambert AJ, Laven J, Kosoy O, Panella A, Biggerstaff BJ, Fischer M, Hayes EB.N Engl J Med. 2009 Jun 11;360(24):2536-43. doi: 10.1056/NEJMoa0805715.
Concurrent outbreaks of dengue, chikungunya and Zika virus infections – an unprecedented epidemic wave of mosquito-borne viruses in the Pacific 2012–2014 Roth, A and Mercier, A and Lepers, C and Hoy, D and Duituturaga, S and Benyon, E and Guillaumot, L and Souarès, Y, Eurosurveillance, 19, 20929 (2014), https://doi.org/10.2807/1560-7917.ES2014.19.41.20929
Published
How to Cite
License
Copyright (c) 2019 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
